Use of interferon-α for prevention of hepatocellular carcinoma in patients with chronic active hepatitis C with cirrhosis

被引：0
|
作者：
Nishiguchi, S [1 ]
Nakatani, S [1 ]
Tamori, A [1 ]
Takeda, T [1 ]
Shiomi, S [1 ]
Seki, S [1 ]
Kuroki, T [1 ]
机构：
[1] Osaka City Univ, Sch Med, Dept Internal Med 3, Abeno Ku, Osaka 5458586, Japan
来源：
HCV AND RELATED LIVER DISEASES | 1999年
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：93 / 102
页数：10
相关论文
共 50 条
  • [1] Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
    Nishiguchi, S
    Shiomi, S
    Nakatani, S
    Takeda, T
    Fukuda, K
    Tamori, A
    Habu, D
    Tanaka, T
    [J]. LANCET, 2001, 357 (9251): : 196 - 197
  • [2] PREVENTION BY INTERFERON-ALPHA OF HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS-C WITH CIRRHOSIS
    NISHIGUCHI, S
    KUROKI, T
    NAKATANI, S
    TAKEDA, T
    NAKAJIMA, S
    SHIOMI, S
    KOBAYASHI, K
    OTANI, S
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A1134 - A1134
  • [3] Interferon (IFN) in cirrhosis and chronic hepatitis C for prevention of hepatocellular carcinoma (HCC).
    Simonetti, R
    Pagliaro, L
    [J]. HEPATOLOGY, 2001, 34 (04) : 669A - 669A
  • [4] The effect of retreatment with interferon-α on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Toyoda, H
    Kumada, T
    Nakano, S
    Takeda, I
    Sugiyama, K
    Kiriyama, S
    Sone, Y
    Hisanaga, Y
    [J]. CANCER, 2000, 88 (01) : 58 - 65
  • [5] Resolution of liver cirrhosis and prevention of hepatocellular carcinoma by interferon therapy against chronic hepatitis C
    Omata, M
    Yoshida, H
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 : 47 - 51
  • [6] Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C
    Yoshida, H
    Tateishi, R
    Arakawa, Y
    Sata, M
    Fujiyama, S
    Nishiguchi, S
    Ishibashi, H
    Yamada, G
    Yokosuka, O
    Shiratori, Y
    Omata, M
    [J]. GUT, 2004, 53 (03) : 425 - 430
  • [7] Immunodulator Effects of Interferon Therapy on Incidence of Cirrhosis and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
    Kutala, Blaise
    Boyer, Nathalie
    Marchand, Corinne Castelnau
    Guigui, Nathalie Giuily
    Sitruk, Veronique
    Asselah, Tarik
    Marcellin, Patrick
    [J]. HEPATOLOGY, 2018, 68 : 407A - 408A
  • [8] Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark
    Hallager, S.
    Ladelund, S.
    Kjaer, M. S.
    Madsen, L. G.
    Belard, E.
    Laursen, A. L.
    Gerstoft, J.
    Roege, B. T.
    Groenbael, K. E.
    Krarup, H. B.
    Christensen, P. B.
    Weis, N.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S706 - S707
  • [9] Interferon for prevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis: A meta-analysis.
    Papadimitropoulos, V
    Papatheodoridis, GV
    Hadziyannis, SJ
    [J]. HEPATOLOGY, 2000, 32 (04) : 569A - 569A
  • [10] Combined thalidomide and interferon-α for chronic hepatitis C-related hepatocellular carcinoma
    Wang, Tsang-En
    Lim, Ken-Hong
    Huang, Ming-Jer
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2007, 3 (01) : 52 - 54
12345